NVO Novo Nordisk stock today: Novo Nordisk shares tumbled after the drugmaker forecast a sales and profit drop for 2026. This outlook comes...

In a bold push for greater influence, a key investor in Novo Nordisk is advocating for a complete overhaul of the board. This strategic man...

Novo Nordisk has appointed Greg Miley, a U.S. pharmaceutical executive, as its new global head of corporate affairs. This move comes as the...

Novo Nordisk is broadening its focus beyond obesity and diabetes by exploring the potential of its weight-loss drugs, including Wegovy, to ...

European shares experienced a rise, propelled by strong performances in the retail sector, particularly Inditex, which reported accelerated...

Novo Nordisk, the maker of Wegovy, plans a major restructuring. The company will cut 9,000 jobs globally. This move aims to save 8 billion ...

European shares rebounded on Wednesday, recovering from a recent dip as investors monitored political developments in France and anticipate...

Novo Nordisk faces potential layoffs after a period of rapid expansion fueled by the success of Wegovy. The company's workforce nearly doub...

Novo Nordisk, the maker of Wegovy, has initiated a global hiring freeze for non-critical roles amid increasing competition and pressure fro...

European stocks experienced a significant downturn, marking the largest single-day drop in over three months, triggered by fresh U.S. tarif...

Anthropic, maker of the Claude chatbot, plans to create 100+ jobs in Europe, mainly in Dublin and London, across sales, engineering, and re...

Novo Nordisk is broadening its Bengaluru operations by increasing senior leadership, doubling global process leaders in India, and boosting...

Corporate India is offering new-age benefits, realizing that attracting and retaining talent requires more than just high salaries. Cos off...

Explosive demand and increased manufacturing capacity for Eli Lilly's weight-loss drug Zepbound drove the company to raise its annual sales...

Doctors say patients come with specific queries regarding weight-loss drugs, which have become both the first preference and the last resor...

The new drugs are known as GLP-1 agonists, which mimic the activity of a hormone that slows digestion and helps people feel full for longer...

Ranked at number five among global pharma and biotech companies in 2020, the Bengaluru-headquartered biopharmaceuticals company said it has...